Filing metadata

Accession number
0001415889-25-002265
Form type
Form 4
Filer
Milestone Pharmaceuticals Inc.
CIK
CIK 1408443
Filed
Jan 29, 2025
Reporting period
Jan 27, 2025
Description
Insider transaction

Explore SEC Filings Hub